查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1784158

空間體學的全球市場

Spatial OMICS
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 228 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球空間體學市場規模將達到 20 億美元

全球空間體學市場規模預計在2024年達到7.677億美元，預計在2024-2030年的分析期內將以17.5%的複合年成長率成長，到2030年將達到20億美元。空間轉錄組學是本報告分析的細分領域之一，預計其複合年成長率將達到19.1%，到分析期結束時規模將達到13億美元。空間基因組學細分領域在分析期間的複合年成長率預計為14.8%。

美國市場規模估計為 2.018 億美元，中國市場預計複合年成長率為 16.5%

美國的空間體學市場規模預計在2024年達到2.018億美元。預計在分析期內（2024-2030年），全球第二大經濟體中國的空間組學市場複合年成長率將達到16.5%，到2030年市場規模將達到3.104億美元。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為16.4%和15.0%。在歐洲，預計德國的複合年成長率約為12.7%。

全球空間體學市場—主要趨勢與促進因素摘要

為什麼空間體學改變分子和細胞生物學的未來？

空間體學正迅速崛起，成為生命科學和生物醫學研究中的一股變革力量，它提供了前所未有的能力，能夠在分子活動的原生空間環境中進行繪製。透過將高解析度成像、轉錄組學、蛋白質組學和代謝體學與空間資訊結合，研究人員如今可以研究基因表現和蛋白質相互作用在不同組織結構和微環境中的變化。這種整合方法與缺乏空間定位的批量定序和單細胞定序截然不同。空間體學使科學家能夠揭示組織異質性、疾病進展和細胞間通訊的複雜性。隨著研究人員不僅尋求了解哪些基因表達，還尋求了解它們在組織基質中的位置和相互作用方式，空間組學在腫瘤學、神經科學、免疫學和發育生物學中的應用正在迅速擴展。尤其是在癌症研究中，空間體學有助於描繪腫瘤邊緣、追蹤免疫細胞浸潤，並識別影響療效的微環境微環境。隨著生命科學進一步走向精準醫療，空間體學成為標靶治療、生物標記發現和下一代診斷的關鍵推動因素。

科技創新如何提高空間體學的解析度和可近性？

空間體學領域受到成像平台、分子標記、條碼策略和數據分析的快速創新所驅動。結合螢光雜合反應(FISH)、免疫組織化學和次世代定序的高通量平台如今能夠同時可視化單一組織切片中數百至數千個 RNA 轉錄物和蛋白質。空間轉錄組學、多重離子束成像 (MIBI)、seqFISH 和 CODEX 等技術為研究人員提供了涵蓋2D和3D組織圖譜的可擴展解決方案。新的化學主導工作流程能夠以更高的靈敏度檢測低豐度分子，而先進的微流體和奈米製造技術正在將空間解析度提升至亞細胞水平。人工智慧和機器學習在複雜空間資料集的分析中也發揮著越來越重要的作用，使得人們能夠解讀先前過於複雜而難以解開的空間模式和生物分子網路。與表觀基因和代謝體學等其他體學層面的整合，進一步拓展了空間分析的深度，為細胞功能、分化和疾病發病機制提供了多維度的洞察。這些技術進步使空間體學更加穩健、可重複且易於使用，使其在實驗室和臨床環境中被更廣泛的受眾所接受。

哪裡的市場需求成長最快？主要的最終用戶是誰？

空間體學技術在學術、製藥、生物技術和臨床研究領域越來越受到關注。在學術機構，研究人員利用空間分析在單細胞層級研究腦迴路、胚胎發育和組織再生。製藥和生物技術公司正在將空間組學應用於藥物研發和轉化研究，尤其是在腫瘤學領域，了解腫瘤微環境對於開發免疫治療方法和標靶干預措施至關重要。委外研發機構(CRO) 也將空間體學整合到其生物標記開發平臺中，為尋求空間分辨資料集的客戶提供專業服務。醫院和診斷實驗室開始將空間體學視為病理學和個人化醫療的未來工具，尤其適用於表徵罕見疾病和對常規治療無反應的腫瘤亞型。美國和歐洲對空間組學的需求尤其強勁，這些地區的研究資金和精準醫療計劃蓬勃發展，但亞太地區正在迅速趕上，中國、日本和韓國在空間生物學基礎設施方面投入了大量資金。私募股權和創業投資對太空體學新興企業和平台開發人員的投資進一步刺激了創新和商業性擴張，從而使空間體學成為生命科學產業的基礎技術。

什麼將推動空間體學市場的長期成長？

空間體學市場的成長受到幾個關鍵因素的驅動，這些因素集中在對空間分辨生物數據日益成長的需求、個人化醫療的發展和技術融合方面。最重要的促進因素之一是人們越來越認知到空間背景對於理解異質性疾病機制至關重要，尤其是在癌症、神經退化和自體免疫疾病中。這種認知刺激了對提供跨各種組織類型和病理的可操作空間資料的工具和平台的投資。定序和成像技術的進步，以及工作流程自動化、可擴展性和連接複用的改進，正在降低成本和複雜性障礙，使其能夠在精英研究中心之外得到更廣泛的應用。學術界和產業界之間日益增多的合作正在加速空間發現向臨床應用的轉化，特別是在診斷、伴隨生物標記開發和治療反應監測領域。監管和資助機構也認知到空間體學的潛力，並為其臨床整合提供津貼和核准。此外，空間資料集的擴展正在推動空間圖譜和多組學資料庫的發展，從而增強跨研究比較和機器學習應用。隨著各學科對高解析度生物學洞察的需求不斷成長，空間體學有望成為下一代生物醫學研究和精準醫療的基本支柱。

部分

技術（空間轉錄組學、空間基因組學、空間蛋白質組學）、產品（儀器、耗材、軟體）、工作流程（樣品製備、儀器分析、數據分析）、樣品類型（FFPE、新鮮冷凍）、最終用戶（學術和轉化研究機構、製藥和生物技術公司）

受訪公司範例

  • 10x Genomics
  • Agilent Technologies Inc.
  • Akoya Biosciences Inc.
  • Biognosys AG
  • Bio-Rad Laboratories Inc.
  • BioSpyder Technologies
  • Bio-Techne Corporation
  • Bruker Corporation
  • Curio Bioscience
  • Diagenode Diagnostics
  • Illumina Inc.
  • Indica Labs Inc.
  • IonPath Inc.
  • Luminex Corporation
  • Miltenyi Biotec
  • Miroculus Inc.
  • NanoString Technologies Inc.
  • Oxford Nanopore Technologies
  • PerkinElmer Inc.
  • Pixelgen Technologies
  • RareCyte Inc.
  • Rebus Biosystems
  • S2 Genomics Inc.
  • Seven Bridges Genomics
  • Standard BioTools（formerly Fluidigm）
  • Takara Bio Inc.
  • Ultivue Inc.
  • Visiopharm A/S
  • Vizgen Corporation
  • ZEISS Group

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有查詢通用的 LLM 或特定產業的SLM，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP33026

Global Spatial OMICS Market to Reach US$2.0 Billion by 2030

The global market for Spatial OMICS estimated at US$767.7 Million in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 17.5% over the analysis period 2024-2030. Spatial Transcriptomics, one of the segments analyzed in the report, is expected to record a 19.1% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Spatial Genomics segment is estimated at 14.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$201.8 Million While China is Forecast to Grow at 16.5% CAGR

The Spatial OMICS market in the U.S. is estimated at US$201.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$310.4 Million by the year 2030 trailing a CAGR of 16.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.4% and 15.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.7% CAGR.

Global Spatial OMICS Market - Key Trends & Drivers Summarized

Why Is Spatial OMICS Reshaping the Future of Molecular and Cellular Biology?

Spatial OMICS is rapidly emerging as a transformative force in life sciences and biomedical research, offering an unprecedented ability to map molecular activity within its native spatial context. By combining high-resolution imaging, transcriptomics, proteomics, and metabolomics with spatial information, researchers can now investigate how gene expression and protein interactions vary across tissue architecture and microenvironments. This integrated approach is a significant leap beyond bulk and single-cell sequencing, which lack spatial positioning. Spatial OMICS is allowing scientists to unravel the complexities of tissue heterogeneity, disease progression, and cell-to-cell communication with exquisite precision. Applications in oncology, neuroscience, immunology, and developmental biology are rapidly expanding, as researchers aim to understand not just what genes are expressed, but where and how they interact within the tissue matrix. Particularly in cancer research, spatial OMICS is helping to delineate tumor margins, track immune cell infiltration, and identify microenvironmental niches that influence treatment response. As life sciences push further into precision medicine, spatial OMICS stands out as a critical enabler of targeted therapies, biomarker discovery, and next-generation diagnostics.

How Are Technology Innovations Elevating the Resolution and Accessibility of Spatial OMICS?

The field of spatial OMICS is being driven forward by rapid innovation in imaging platforms, molecular labeling, barcoding strategies, and data analytics. High-throughput platforms combining fluorescence in situ hybridization (FISH), immunohistochemistry, and next-generation sequencing are now capable of visualizing hundreds to thousands of RNA transcripts and proteins simultaneously within a single tissue section. Technologies such as spatial transcriptomics, multiplexed ion beam imaging (MIBI), seqFISH, and CODEX are providing researchers with scalable solutions across both 2D and 3D tissue landscapes. New chemistry-driven workflows are making it possible to detect low-abundance molecules with greater sensitivity, while advanced microfluidics and nanofabrication techniques are enhancing spatial resolution down to subcellular levels. AI and machine learning are also playing an increasingly vital role in analyzing complex spatial datasets, enabling the interpretation of spatial patterns and biomolecular networks that were previously too intricate to resolve. Integration with other omics layers-such as epigenomics and metabolomics-is further extending the depth of spatial analysis, providing multi-dimensional insights into cell function, differentiation, and disease pathology. These technical advancements are making spatial OMICS more robust, reproducible, and user-friendly, opening access to a broader segment of research labs and clinical institutions.

Where Is Market Demand Emerging Most Rapidly, and Who Are the Key End Users?

Spatial OMICS technologies are gaining traction across academic, pharmaceutical, biotechnology, and clinical research settings. In academic institutions, researchers are leveraging spatial analysis to study brain circuitry, embryonic development, and tissue regeneration at a single-cell level. Pharmaceutical and biotech companies are deploying spatial OMICS for drug discovery and translational research, particularly in oncology, where understanding the tumor microenvironment is crucial to developing immune-based therapies and targeted interventions. Contract research organizations (CROs) are also integrating spatial OMICS into biomarker development pipelines, offering specialized services for clients pursuing spatially resolved datasets. Hospitals and diagnostic labs are beginning to explore spatial OMICS as a future tool in pathology and personalized medicine, especially for characterizing rare diseases or tumor subtypes that don’t respond to conventional treatments. Demand is particularly high in the United States and Europe, where research funding and precision medicine initiatives are strong, but Asia-Pacific is rapidly catching up, with major investments in spatial biology infrastructure across China, Japan, and South Korea. Private equity and venture capital investment in spatial OMICS startups and platform developers is further fueling innovation and commercial expansion. These converging forces are establishing spatial OMICS as a cornerstone technology across the life sciences landscape.

What’s Driving the Long-term Growth of the Spatial OMICS Market?

The growth in the spatial OMICS market is driven by several critical factors centered around the rising demand for spatially resolved biological data, the evolution of personalized medicine, and technological convergence. One of the foremost drivers is the growing realization that spatial context is essential for understanding disease mechanisms, particularly in heterogeneous conditions such as cancer, neurodegeneration, and autoimmune disorders. This insight is fueling investment in tools and platforms that provide actionable spatial data across various tissue types and disease states. The advancement of sequencing and imaging technologies, along with improvements in workflow automation, scalability, and multiplexing, is reducing cost and complexity barriers, enabling wider adoption beyond elite research centers. Increasing collaborations between academia and industry are accelerating the translation of spatial discoveries into clinical applications, particularly in the realm of diagnostics, companion biomarker development, and therapeutic response monitoring. Regulatory agencies and funding bodies are also recognizing the potential of spatial OMICS, directing grants and approvals toward its clinical integration. Additionally, the expansion of spatial datasets is powering the development of spatial atlases and multi-omic databases that enhance cross-study comparisons and machine learning applications. As the need for high-resolution biological insights continues to rise across disciplines, spatial OMICS is positioned to become a foundational pillar of next-generation biomedical research and precision healthcare.

SCOPE OF STUDY:

The report analyzes the Spatial OMICS market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Spatial Transcriptomics, Spatial Genomics, Spatial Proteomics); Product (Instruments, Consumables, Software); Workflow (Sample Preparation, Instrumental Analysis, Data Analysis); Sample Type (FFPE, Fresh Frozen); End-Use (Academic & Translational Research Institutes, Pharma & Biotech Companies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • 10x Genomics
  • Agilent Technologies Inc.
  • Akoya Biosciences Inc.
  • Biognosys AG
  • Bio-Rad Laboratories Inc.
  • BioSpyder Technologies
  • Bio-Techne Corporation
  • Bruker Corporation
  • Curio Bioscience
  • Diagenode Diagnostics
  • Illumina Inc.
  • Indica Labs Inc.
  • IonPath Inc.
  • Luminex Corporation
  • Miltenyi Biotec
  • Miroculus Inc.
  • NanoString Technologies Inc.
  • Oxford Nanopore Technologies
  • PerkinElmer Inc.
  • Pixelgen Technologies
  • RareCyte Inc.
  • Rebus Biosystems
  • S2 Genomics Inc.
  • Seven Bridges Genomics
  • Standard BioTools (formerly Fluidigm)
  • Takara Bio Inc.
  • Ultivue Inc.
  • Visiopharm A/S
  • Vizgen Corporation
  • ZEISS Group

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Spatial OMICS - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Explosive Growth in Single-cell Biology Throws the Spotlight on Spatial OMICS as the Next Frontier in Tissue-level Resolution
    • Rising Focus on Tumor Microenvironment Characterization Spurs Adoption of Spatial Transcriptomics in Cancer Research
    • Here's How Precision Medicine Initiatives Expand the Addressable Market for Spatially Resolved Multi-omic Platforms
    • Integration of Spatial Genomics and Proteomics Strengthens the Business Case for Holistic Tissue Analysis Tools
    • Demand for High-resolution Mapping of Cellular Architecture Drives Innovation in Spatial Imaging and Label-free Detection
    • Here's the Story: Spatial OMICS Emerges as a Critical Enabler in Drug Discovery, Target Validation, and Biomarker Development
    • Advancements in In Situ Sequencing and Multiplexed Imaging Propel Growth of Scalable, High-throughput Spatial Platforms
    • AI and Machine Learning Integration Enhances Spatial Data Interpretation and Accelerates Biological Insight Generation
    • Rising Investment by Biopharma in Oncology, Neuroscience, and Immunology Applications Drives Commercial Uptake of Spatial OMICS
    • Emergence of Cloud-based Bioinformatics Solutions Unlocks Opportunities for Scalable Spatial Data Storage and Analysis
    • Growing Demand for Spatial Resolution in FFPE-compatible Assays Expands Clinical Research and Diagnostic Use Cases
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Spatial OMICS Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Spatial OMICS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Spatial OMICS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Spatial Transcriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Spatial Transcriptomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Spatial Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Spatial Genomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Spatial Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Spatial Proteomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for FFPE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for FFPE by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Fresh Frozen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Fresh Frozen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Academic & Translational Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Academic & Translational Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Sample Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Sample Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Instrumental Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Instrumental Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Data Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Data Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 30: USA Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • CANADA
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • JAPAN
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • CHINA
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 60: China Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • EUROPE
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Spatial OMICS by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Spatial OMICS by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • FRANCE
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 82: France Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: France 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 84: France Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: France 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 88: France Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: France 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 90: France Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: France 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • GERMANY
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 94: Germany Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Germany 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 96: Germany Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Germany 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 100: Germany Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Germany 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • ITALY
    • TABLE 102: Italy Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Italy 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 106: Italy Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Italy 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 108: Italy Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Italy 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • UNITED KINGDOM
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 112: UK Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: UK 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 114: UK Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: UK 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 118: UK Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: UK 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 120: UK Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: UK 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 124: Rest of Europe Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of Europe 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 126: Rest of Europe Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Europe 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 130: Rest of Europe Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of Europe 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 132: Asia-Pacific Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Asia-Pacific 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 136: Asia-Pacific Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Asia-Pacific 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 138: Asia-Pacific Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Asia-Pacific 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 142: Rest of World Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Rest of World 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 144: Rest of World Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Rest of World 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 148: Rest of World Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Rest of World 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 150: Rest of World Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Rest of World 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030

IV. COMPETITION